Free Trial

Transcat (TRNS) Projected to Post Earnings on Wednesday

Transcat logo with Computer and Technology background

Transcat (NASDAQ:TRNS - Get Free Report) is expected to announce its Q1 2026 earnings results after the market closes on Wednesday, August 6th. Analysts expect the company to announce earnings of $0.41 per share and revenue of $72.28 million for the quarter.

Transcat (NASDAQ:TRNS - Get Free Report) last posted its quarterly earnings data on Monday, May 19th. The scientific and technical instruments company reported $0.64 EPS for the quarter, missing the consensus estimate of $0.66 by ($0.02). Transcat had a return on equity of 6.47% and a net margin of 5.21%. The firm had revenue of $77.13 million for the quarter, compared to analysts' expectations of $76.40 million. The company's quarterly revenue was up 8.8% on a year-over-year basis. On average, analysts expect Transcat to post $2 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Transcat Price Performance

NASDAQ:TRNS traded down $1.88 during trading hours on Friday, hitting $74.55. 63,573 shares of the stock were exchanged, compared to its average volume of 74,225. Transcat has a 52-week low of $67.56 and a 52-week high of $133.72. The firm's fifty day moving average price is $83.13 and its 200 day moving average price is $81.76. The company has a current ratio of 2.29, a quick ratio of 1.87 and a debt-to-equity ratio of 0.11. The company has a market cap of $694.81 million, a P/E ratio of 47.79 and a beta of 0.71.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Transcat stock. Jane Street Group LLC acquired a new stake in Transcat, Inc. (NASDAQ:TRNS - Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 22,480 shares of the scientific and technical instruments company's stock, valued at approximately $1,674,000. Jane Street Group LLC owned about 0.24% of Transcat as of its most recent filing with the Securities and Exchange Commission (SEC). 98.34% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

TRNS has been the subject of a number of analyst reports. Wall Street Zen upgraded Transcat from a "sell" rating to a "hold" rating in a research report on Wednesday, May 28th. HC Wainwright restated a "buy" rating and issued a $116.00 price target on shares of Transcat in a research report on Wednesday, June 25th. Finally, Lake Street Capital initiated coverage on Transcat in a research report on Thursday, July 10th. They issued a "buy" rating and a $105.00 price target for the company. Three analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, Transcat has an average rating of "Moderate Buy" and a consensus price target of $112.20.

Get Our Latest Analysis on Transcat

Transcat Company Profile

(Get Free Report)

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.

Featured Stories

Earnings History for Transcat (NASDAQ:TRNS)

Should You Invest $1,000 in Transcat Right Now?

Before you consider Transcat, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Transcat wasn't on the list.

While Transcat currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Value Plays Set to Explode
5 Stocks to BUY NOW in August 2025
The $2.5B Merger No One Is Talking About

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines